Sottile, M. L., Gómez, L. C., Redondo, A., Ibarra, J., García, M. B., Gonzalez, L., . . . Nadin, S. B. (2024). Relevance of Comet Assay and Phosphorylated-Hsp90α in Cancer Patients’ Peripheral Blood Leukocytes as Tools to Assess Cisplatin-based Chemotherapy Clinical Response and Disease Outcome. The journal of histochemistry and cytochemistry, 72(3), 173-188. https://doi.org/10.1369/00221554241236241
Chicago Style (17th ed.) CitationSottile, Mayra L., Laura C. Gómez, Analía Redondo, Jorge Ibarra, María B. García, Lucía Gonzalez, Laura M. Vargas-Roig, and Silvina B. Nadin. "Relevance of Comet Assay and Phosphorylated-Hsp90α in Cancer Patients’ Peripheral Blood Leukocytes as Tools to Assess Cisplatin-based Chemotherapy Clinical Response and Disease Outcome." The Journal of Histochemistry and Cytochemistry 72, no. 3 (2024): 173-188. https://doi.org/10.1369/00221554241236241.
MLA (9th ed.) CitationSottile, Mayra L., et al. "Relevance of Comet Assay and Phosphorylated-Hsp90α in Cancer Patients’ Peripheral Blood Leukocytes as Tools to Assess Cisplatin-based Chemotherapy Clinical Response and Disease Outcome." The Journal of Histochemistry and Cytochemistry, vol. 72, no. 3, 2024, pp. 173-188, https://doi.org/10.1369/00221554241236241.